|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$95,590.98 |
3.00% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$90,270.15 |
2.83% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$84,945.05 |
2.66% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$81,079.43 |
2.54% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$80,725.65 |
2.53% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$80,637.77 |
2.53% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$79,568.98 |
2.49% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$77,544.00 |
2.43% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$76,293.36 |
2.39% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$76,225.14 |
2.39% |
| Waters Corporation |
WAT |
941848103 |
184 |
$75,765.68 |
2.38% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$74,807.94 |
2.35% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$74,723.20 |
2.34% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$72,109.78 |
2.26% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$71,891.20 |
2.25% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$70,763.42 |
2.22% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$70,145.53 |
2.20% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$69,666.71 |
2.18% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$68,618.66 |
2.15% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$67,136.79 |
2.10% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$66,234.00 |
2.08% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$64,939.87 |
2.04% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$64,904.70 |
2.03% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$64,238.85 |
2.01% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$63,868.56 |
2.00% |
| Steris Plc |
STE |
G8473T100 |
265 |
$63,311.15 |
1.98% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$63,192.96 |
1.98% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$61,761.92 |
1.94% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$61,894.74 |
1.94% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$60,441.16 |
1.89% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,217.03 |
1.89% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$60,170.94 |
1.89% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$59,853.60 |
1.88% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$58,862.58 |
1.85% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$58,110.12 |
1.82% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$58,024.44 |
1.82% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$56,772.90 |
1.78% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$56,169.80 |
1.76% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$55,770.31 |
1.75% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$54,421.93 |
1.71% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$52,507.03 |
1.65% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$51,139.40 |
1.60% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$49,126.62 |
1.54% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$48,447.85 |
1.52% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$48,189.30 |
1.51% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$47,206.26 |
1.48% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$43,400.28 |
1.36% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$42,855.00 |
1.34% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,731.66 |
1.31% |
| US Dollar |
$USD |
|
13,396 |
$13,396.12 |
0.42% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|